![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2020 10:28 | Buys flooding in again, will test 60p soon :-) | ![]() tburns | |
22/4/2020 10:11 | The seller has held this back - been selling since last Thursday but RSP looks fine now. Clear for lift off | ![]() imjustdandy | |
22/4/2020 10:10 | Nobby, 50+ consultants working acrooss 4 keystreams suggests this trial is on fire! | ![]() likya123 | |
22/4/2020 10:09 | Massive sells at 8am to 8.15am | ![]() imjustdandy | |
22/4/2020 10:09 | Marsden could say absolutely nothing that isn't already in the public domain. As Nobby has said many times - the only thing which will shift the share price (up or down) is the result of the blinded SNG trial - unless the WHO/Trump/Wuhan come up with a recommendation to treat the pre-ventilated with inhaled interferon beta. | ![]() toffeeman | |
22/4/2020 10:05 | Sells printing around 8am suggests seller out | ![]() imjustdandy | |
22/4/2020 10:04 | Gonna blow this week | ![]() imjustdandy | |
22/4/2020 10:03 | From lse board just now.... Richard confirmed Synairgen now have +50 consultants working across four key work streams. Hospital Trial At home Trials - see how this can be achieved Manufacturing Regulatory What Synairgen has achieved in 8 weeks would take most companies 8 months. This journey is just starting. | ![]() likya123 | |
22/4/2020 09:53 | Look at that blocks of sells trying to stem this mornings rise.Well we can't go down everyday ! | ![]() cambradjones | |
22/4/2020 09:52 | Massive upside? Means risk as well dont get too deep in pharma stocks they can be unforgiving Just have a balanced view | ![]() ic0gcds00 | |
22/4/2020 09:50 | Looking good:) | ![]() bmnsa | |
22/4/2020 09:45 | Just no reason to sell now ... the downside compared to the massive upside. | ![]() peachie 74 | |
22/4/2020 09:38 | Did a good job on the Andrew Scott one, need a repeat on media here | ![]() 141jaffa | |
22/4/2020 09:34 | So this should rocket. The world will always be scared of the next virus, which by nature often attack lungs. Synairgen could be sat on a product that saves millions of lives. Not just with Covid 19 , but future outbreaks. Plus it’s general use in CPOD and asthma. The 2 main reasons for hospital admissions | ![]() peachie 74 | |
22/4/2020 09:29 | If Richard can come on and explain rationally what benefit interferon-beta-1a can provide the lungs to help combat the virus this will be hugely +ve PR. Keep listening. | ![]() tburns | |
22/4/2020 09:28 | About time too. | ![]() 2nell | |
22/4/2020 09:26 | Massive order been filled I reckon - watch this space for rocket news | ![]() imjustdandy | |
22/4/2020 09:25 | Looks like the rebound is going to be very rapid here... | ![]() nobbygnome | |
22/4/2020 09:23 | Don’t curse it Nobby | ![]() talk2dubya | |
22/4/2020 09:22 | I know they are trying to get Richard Marsden on.... Meanwhile what is that strange blue colour on my screen... | ![]() nobbygnome | |
22/4/2020 09:20 | Just listening to Nicky Campbell's phone in, talking mainly about anti-virals and vaccine trials starting tomoz. | ![]() tburns | |
22/4/2020 09:18 | Just topped up too! | ![]() blueblood | |
22/4/2020 09:16 | 90k ‘sell’ And up we go! Someone’s taking the p!ss.... | ![]() wetdream | |
22/4/2020 09:10 | I’ve just bought more. There is a big rise due here I reckon | ![]() peachie 74 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions